These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36468719)

  • 1. A novel splice-site variant of the LAMB3 gene is associated with junctional epidermolysis bullosa.
    Liang B; Meng D; Cao Y; Zhang D; Zhou J; Chen M; Chen G; Huang H
    Eur J Dermatol; 2022 Sep; 32(5):632-636. PubMed ID: 36468719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of whole exome sequencing in elucidating the phenotype and genotype spectrum of junctional epidermolysis bullosa: A preliminary experience of a tertiary care centre in India.
    Yenamandra VK; Vellarikkal SK; Kumar M; Chowdhury MR; Jayarajan R; Verma A; Scaria V; Sivasubbu S; Ray SB; Dinda AK; Kabra M; Kaur P; Sharma VK; Sethuraman G
    J Dermatol Sci; 2017 Apr; 86(1):30-36. PubMed ID: 28087116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of non-lethal junctional epidermolysis bullosa: identification of a 38 basepair insertion and a splice site mutation in exon 14 of the LAMB3 gene.
    Cserhalmi-Friedman PB; Baden H; Burgeson RE; Christiano AM
    Exp Dermatol; 1998; 7(2-3):105-11. PubMed ID: 9583749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herlitz junctional epidermolysis bullosa: novel and recurrent mutations in the LAMB3 gene and the population carrier frequency.
    Nakano A; Pfendner E; Hashimoto I; Uitto J
    J Invest Dermatol; 2000 Sep; 115(3):493-8. PubMed ID: 11023379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant splicing as potential modifier of the phenotype of junctional epidermolysis bullosa.
    Mittwollen R; Wohlfart S; Park J; Grosch E; Has C; Hohenester E; Schneider H; Hammersen J
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2127-2134. PubMed ID: 32124492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominance of the recurrent mutation R635X in the LAMB3 gene in European patients with Herlitz junctional epidermolysis bullosa has implications for mutation detection strategy.
    Pulkkinen L; Meneguzzi G; McGrath JA; Xu Y; Blanchet-Bardon C; Ortonne JP; Christiano AM; Uitto J
    J Invest Dermatol; 1997 Aug; 109(2):232-7. PubMed ID: 9242513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-Phenotype Correlation in Junctional Epidermolysis Bullosa: Signposts to Severity.
    Wen D; Hunjan M; Bardhan A; Harper N; Ogboli M; Ozoemena L; Liu L; Fine JD; Chapple I; Balacco DL; Heagerty A
    J Invest Dermatol; 2024 Jun; 144(6):1334-1343.e14. PubMed ID: 38157931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes.
    Nakano A; Chao SC; Pulkkinen L; Murrell D; Bruckner-Tuderman L; Pfendner E; Uitto J
    Hum Genet; 2002 Jan; 110(1):41-51. PubMed ID: 11810295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-exome sequencing, without prior linkage, identifies a mutation in LAMB3 as a cause of dominant hypoplastic amelogenesis imperfecta.
    Poulter JA; El-Sayed W; Shore RC; Kirkham J; Inglehearn CF; Mighell AJ
    Eur J Hum Genet; 2014 Jan; 22(1):132-5. PubMed ID: 23632796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
    McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
    J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First case report of complete paternal isodisomy of chromosome 10 harbouring a novel variant in COL17A1 that causes junctional epidermolysis bullosa intermediate.
    Wang Y; Yu D; Wei W; Zheng H; Liu MH; Ma L; Qin LN; Wang NZ; Li JX; Wang JJ; Bi XL; Yan HL
    BMC Med Genomics; 2022 Jun; 15(1):136. PubMed ID: 35717189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa.
    Posteraro P; De Luca N; Meneguzzi G; El Hachem M; Angelo C; Gobello T; Tadini G; Zambruno G; Castiglia D
    J Invest Dermatol; 2004 Oct; 123(4):639-48. PubMed ID: 15373767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Junctional epidermolysis bullosa with extensive lung involvement in three patients with a LAMB3 Mutation.
    Ahmed F; Young LR; Perman MJ
    Pediatr Dermatol; 2022 Mar; 39(2):264-267. PubMed ID: 35178765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa.
    Christiano AM; Pulkkinen L; Eady RA; Uitto J
    J Invest Dermatol; 1996 Apr; 106(4):775-7. PubMed ID: 8618020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted next-generation sequencing identifies a novel mutation of LAMB3 in a Chinese neonatal patient presented with junctional epidermolysis bullosa.
    Wang H; Yang Y; Zhou J; Cao J; He X; Li L; Gao S; Mao B; Tian P; Zhou A
    Medicine (Baltimore); 2018 Dec; 97(49):e13225. PubMed ID: 30544381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands.
    Yuen WY; Lemmink HH; van Dijk-Bos KK; Sinke RJ; Jonkman MF
    Br J Dermatol; 2011 Dec; 165(6):1314-22. PubMed ID: 21801158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laminin 5 genes and Herlitz junctional epidermolysis bullosa: novel mutations and polymorphisms in the LAMB3 and LAMC2 genes. Mutations in brief no. 190. Online.
    Kon A; Pulkkinen L; Hara M; Tamai K; Tagami H; Hashimoto I; Uitto J
    Hum Mutat; 1998; 12(4):288. PubMed ID: 10660342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound heterozygosity for nonsense ans missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa.
    McGarth JA; Christiano AM; Pulkkinen L; Eady RA; Uitto J
    J Invest Dermatol; 1996 May; 106(5):1157-9. PubMed ID: 8618058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole exome sequencing in a sample of Peruvian patients diagnosed with epidermolysis bullosa.
    Zevallos-Morales A; Iberico RT; Obispo D; Danos P; Sanchez RM; Fujita R; Guevara-Fujita ML
    Dermatol Online J; 2022 Oct; 28(5):. PubMed ID: 36809127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound heterozygosity for an out-of-frame deletion and a splice site mutation in the LAMB3 gene causes nonlethal junctional epidermolysis bullosa.
    Posteraro P; Sorvillo S; Gagnoux-Palacios L; Angelo C; Paradisi M; Meneguzzi G; Castiglia D; Zambruno G
    Biochem Biophys Res Commun; 1998 Feb; 243(3):758-64. PubMed ID: 9501007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.